| Name | Title | Contact Details |
|---|
Michael Smith Genome Sciences Centre is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ntd laboratories inc is a Huntington Station, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Deep Expertise, Broad Reach Versiti is a strategic affiliation of successful healthcare organizations whose vision is to improve the health of patients as the national leader in innovative transfusion solutions for healthcare systems. Everyone in our nation’s healthcare system is seeking new and better ways to provide high-quality patient care at an affordable cost. Organizations that offer vital resources must also look at new models of operating that will continually improve patient outcomes, increase the quality of service, and reduce the cost of healthcare. Working together, Versiti offers hospitals a more comprehensive range of services, including transfusion medicine, transplantation, stem cell and cellular therapies, hematology, oncology and genomics. We are passionate about improving the lives of our patients and hospital partners. We apply our deep expertise in blood-related service to solve the toughest challenges Our expertise and resources lead to new products, solutions and services to meet patient and hospital needs. We Believe: By bringing together the industry’s best and brightest, the depth and breadth of our expertise sets us apart Our relationships with donors, patients and hospital partners inspire everything we do We offer best-in-class products and services Our work sets new standards for quality, efficiency and care Our approach will reshape our industry and create new ways to help people and communities thrive
Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.
G F D Courier Corp is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.